{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T02:54:35Z","timestamp":1721357675789},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,17]]},"DOI":"10.7759\/cureus.37670","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T09:11:52Z","timestamp":1681722712000},"source":"Crossref","is-referenced-by-count":3,"title":["Chemotherapy May Obviate Prophylactic Femoral Nail Surgery for Multiple Myeloma Patients With High Mirels\u2019 Score Lesions and Impending Pathological Hip Fracture"],"prefix":"10.7759","author":[{"given":"Omkaar","family":"Divekar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bisola","family":"Ajayi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Barkham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmin","family":"Reyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fenella","family":"Willis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darren","family":"Lui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ross","family":"Coomber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082113","article-title":"Multiple myeloma associated bone disease","volume":"12","author":"Rasch S","year":"2020","unstructured":"Rasch S, Lund T, Asmussen JT, Lerberg Nielsen A, Faebo Larsen R, \u00d8sterheden Andersen M, Abildgaard N. Multiple myeloma associated bone disease. Cancers (Basel). 2020, 12:2113. 10.3390\/cancers12082113","journal-title":"Cancers (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4137\/CGM.S16817","article-title":"Bone disease in multiple myeloma: pathophysiology and management","volume":"7","author":"Hameed A","year":"2014","unstructured":"Hameed A, Brady JJ, Dowling P, Clynes M, O'Gorman P. Bone disease in multiple myeloma: pathophysiology and management. Cancer Growth Metastasis. 2014, 7:33-42. 10.4137\/CGM.S16817","journal-title":"Cancer Growth Metastasis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5413.143915","article-title":"Management of skeletal metastases: an orthopaedic surgeon's guide","volume":"49","author":"Agarwal MG","year":"2015","unstructured":"Agarwal MG, Nayak P. Management of skeletal metastases: an orthopaedic surgeon's guide. Indian J Orthop. 2015, 49:83-100. 10.4103\/0019-5413.143915","journal-title":"Indian J Orthop"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13577","article-title":"Optimizing the management of patients with spinal myeloma disease","volume":"171","author":"Molloy S","year":"2015","unstructured":"Molloy S, Lai M, Pratt G, et al.. Optimizing the management of patients with spinal myeloma disease. Br J Haematol. 2015, 171:332-43. 10.1111\/bjh.13577","journal-title":"Br J Haematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.242","article-title":"International staging system for multiple myeloma","volume":"23","author":"Greipp PR","year":"2005","unstructured":"Greipp PR, San Miguel J, Durie BG, et al.. International staging system for multiple myeloma. J Clin Oncol. 2005, 23:3412-20. 10.1200\/JCO.2005.04.242","journal-title":"J Clin Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404284","article-title":"International uniform response criteria for multiple myeloma","volume":"20","author":"Durie BG","year":"2006","unstructured":"Durie BG, Harousseau JL, Miguel JS, et al.. International uniform response criteria for multiple myeloma. Leukemia. 2006, 20:1467-73. 10.1038\/sj.leu.2404284","journal-title":"Leukemia"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple myeloma","volume":"364","author":"Palumbo A","year":"2011","unstructured":"Palumbo A, Anderson K. Multiple myeloma. N Engl J Med. 2011, 364:1046-60. 10.1056\/NEJMra1011442","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-40320-5_1","article-title":"MGUS and smoldering multiple myeloma: diagnosis and epidemiology","volume":"169","author":"Mateos MV","year":"2016","unstructured":"Mateos MV, Landgren O. MGUS and smoldering multiple myeloma: diagnosis and epidemiology. Cancer Treat Res. 2016, 169:3-12. 10.1007\/978-3-319-40320-5_1","journal-title":"Cancer Treat Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-00359-2","article-title":"Multiple myeloma current treatment algorithms","volume":"10","author":"Rajkumar SV","year":"2020","unstructured":"Rajkumar SV, Kumar S. Multiple myeloma current treatment algorithms. Blood Cancer J. 2020, 10:94. 10.1038\/s41408-020-00359-2","journal-title":"Blood Cancer J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2586","article-title":"Multiple myeloma: every year a new standard?","volume":"37 Suppl 1","author":"Rajkumar SV","year":"2019","unstructured":"Rajkumar SV. Multiple myeloma: every year a new standard?. Hematol Oncol. 2019, 37 Suppl 1:62-5. 10.1002\/hon.2586","journal-title":"Hematol Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-02-408922","article-title":"Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA\/GEM study","volume":"120","author":"Rosi\u00f1ol L","year":"2012","unstructured":"Rosi\u00f1ol L, Oriol A, Teruel AI, et al.. Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA\/GEM study. Blood. 2012, 120:1589-96. 10.1182\/blood-2012-02-408922","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/BLOOD.V112.11.158.158","article-title":"Superior complete response rate and progression-free survival after autologous transplantation with up-front velcade-thalidomide- dexamethasone compared with thalidomide-dexamethasone in newly diagnosed multiple myeloma","volume":"112","author":"Cavo M","year":"2008","unstructured":"Cavo M, Tacchetti P, Patriarca F, et al.. Superior complete response rate and progression-free survival after autologous transplantation with up-front velcade-thalidomide- dexamethasone compared with thalidomide-dexamethasone in newly diagnosed multiple myeloma. Blood. 2008, 112:158. 10.1182\/BLOOD.V112.11.158.158","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn796","article-title":"The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network","volume":"20","author":"Terpos E","year":"2009","unstructured":"Terpos E, Sezer O, Croucher PI, et al.. The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network. Ann Oncol. 2009, 20:1303-17. 10.1093\/annonc\/mdn796","journal-title":"Ann Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-0681","article-title":"Treatment for myeloma bone disease","volume":"12","author":"Yeh HS","year":"2006","unstructured":"Yeh HS, Berenson JR. Treatment for myeloma bone disease. Clin Cancer Res. 2006, 12:6279s-84s. 10.1158\/1078-0432.CCR-06-0681","journal-title":"Clin Cancer Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-009-0829-0","article-title":"Role of radiography, MRI and FDG-PET\/CT in diagnosing, staging and therapeutical evaluation of patients with multiple myeloma","volume":"88","author":"L\u00fctje S","year":"2009","unstructured":"L\u00fctje S, de Rooy JW, Croockewit S, Koedam E, Oyen WJ, Raymakers RA. Role of radiography, MRI and FDG-PET\/CT in diagnosing, staging and therapeutical evaluation of patients with multiple myeloma. Ann Hematol. 2009, 88:1161-8. 10.1007\/s00277-009-0829-0","journal-title":"Ann Hematol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1102\/1470-7330.2004.0010","article-title":"Multiple myeloma","volume":"4 Spec No A","author":"Collins CD","year":"2004","unstructured":"Collins CD. Multiple myeloma. Cancer Imaging. 2004, 4 Spec No A:S47-53. 10.1102\/1470-7330.2004.0010","journal-title":"Cancer Imaging"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12346","article-title":"Comparison of modern and conventional imaging techniques in establishing multiple myeloma-related bone disease: a systematic review","volume":"162","author":"Regelink JC","year":"2013","unstructured":"Regelink JC, Minnema MC, Terpos E, et al.. Comparison of modern and conventional imaging techniques in establishing multiple myeloma-related bone disease: a systematic review. Br J Haematol. 2013, 162:50-61. 10.1111\/bjh.12346","journal-title":"Br J Haematol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2015.11.007","article-title":"Multiple myeloma: diagnosis and treatment","volume":"91","author":"Rajkumar SV","year":"2016","unstructured":"Rajkumar SV, Kumar S. Multiple myeloma: diagnosis and treatment. Mayo Clin Proc. 2016, 91:101-19. 10.1016\/j.mayocp.2015.11.007","journal-title":"Mayo Clin Proc"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/os.12267","article-title":"Consensus on surgical management of myeloma bone disease","volume":"8","author":"The Surgeon's Committee of the Chinese Myeloma Working Group of the International Myeloma Foundation","year":"2016","unstructured":"The Surgeon's Committee of the Chinese Myeloma Working Group of the International Myeloma Foundation. Consensus on surgical management of myeloma bone disease. Orthop Surg. 2016, 8:263-9. 10.1111\/os.12267","journal-title":"Orthop Surg"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-1040(05)84485-X","article-title":"Centromedullary nailing of the femur for bone metastasis: clinical and radiological evaluation using the Tokuhashi score in 24 patients [Article in French]","volume":"91","author":"Obert L","year":"2005","unstructured":"Obert L, Jarry A, Lepage D, Jeunet L, Tropet Y, Vichard P, Garbuio P. Centromedullary nailing of the femur for bone metastasis: clinical and radiological evaluation using the Tokuhashi score in 24 patients [Article in French]. Rev Chir Orthop Reparatrice Appar Mot. 2005, 91:737-45. 10.1016\/S0035-1040(05)84485-X","journal-title":"Rev Chir Orthop Reparatrice Appar Mot"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s00264-013-2108-x","article-title":"Benefits of early intramedullary nailing in femoral metastases","volume":"38","author":"Arvinius C","year":"2014","unstructured":"Arvinius C, Parra JL, Mateo LS, Maroto RG, Borrego AF, Stern LL. Benefits of early intramedullary nailing in femoral metastases. Int Orthop. 2014, 38:129-32. 10.1007\/s00264-013-2108-x","journal-title":"Int Orthop"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/01.blo.0000093045.56370.dd","article-title":"Metastatic disease in long bones: a proposed scoring system for diagnosing impending pathologic fractures. 1989","author":"Mirels H","year":"2003","unstructured":"Mirels H. Metastatic disease in long bones: a proposed scoring system for diagnosing impending pathologic fractures. 1989. Clin Orthop Relat Res. 2003, S4-13. 10.1097\/01.blo.0000093045.56370.dd","journal-title":"Clin Orthop Relat Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/01.blo.0000093842.72468.73","article-title":"Critical evaluation of Mirels' rating system for impending pathologic fractures","volume":"415","author":"Damron TA","year":"2003","unstructured":"Damron TA, Morgan H, Prakash D, Grant W, Aronowitz J, Heiner J. Critical evaluation of Mirels' rating system for impending pathologic fractures. Clin Orthop Relat Res. 2003, 415:S201-7. 10.1097\/01.blo.0000093842.72468.73","journal-title":"Clin Orthop Relat Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1302\/0301-620X.100B8.BJJ-2018-0300.R1","article-title":"The validity of the Mirels score for predicting impending pathological fractures of the lower limb","volume":"100-B","author":"Howard EL","year":"2018","unstructured":"Howard EL, Shepherd KL, Cribb G, Cool P. The validity of the Mirels score for predicting impending pathological fractures of the lower limb. Bone Joint J. 2018, 100-B:1100-5. 10.1302\/0301-620X.100B8.BJJ-2018-0300.R1","journal-title":"Bone Joint J"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.injury.2018.09.044","article-title":"Treatment of pathologic fractures of the proximal femur","volume":"49 Suppl 3","author":"Angelini A","year":"2018","unstructured":"Angelini A, Trovarelli G, Berizzi A, Pala E, Breda A, Maraldi M, Ruggieri P. Treatment of pathologic fractures of the proximal femur. Injury. 2018, 49 Suppl 3:S77-83. 10.1016\/j.injury.2018.09.044","journal-title":"Injury"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00135-5","article-title":"Multiple myeloma","volume":"397","author":"van de Donk NWCJ","year":"2021","unstructured":"van de Donk NWCJ, Pawlyn C, Yong KL. Multiple myeloma. Lancet. 2021, 397:410-27. 10.1016\/S0140-6736(21)00135-5","journal-title":"Lancet"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s11999-010-1326-4","article-title":"In brief: classifications in brief: Mirels' classification: metastatic disease in long bones and impending pathologic fracture","volume":"468","author":"Jawad MU","year":"2010","unstructured":"Jawad MU, Scully SP. In brief: classifications in brief: Mirels' classification: metastatic disease in long bones and impending pathologic fracture. Clin Orthop Relat Res. 2010, 468:2825-7. 10.1007\/s11999-010-1326-4","journal-title":"Clin Orthop Relat Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/128604-chemotherapy-may-obviate-prophylactic-femoral-nail-surgery-for-multiple-myeloma-patients-with-high-mirels-score-lesions-and-impending-pathological-hip-fracture","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:58:30Z","timestamp":1707508710000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/128604-chemotherapy-may-obviate-prophylactic-femoral-nail-surgery-for-multiple-myeloma-patients-with-high-mirels-score-lesions-and-impending-pathological-hip-fracture"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,17]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.37670","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,17]]}}}